Spotlight
Money Desk
Obituaries
Classifieds
Families First
News
Weather
Specialists
Sports
Business
Opinion
Consumer
Health
Life
Out & About
Login
Recommended
Your ultimate guide to the 2024 North Carolina State Fair
Recommended
North Carolina Voter Guide 2024: Who's running, how, where, when to vote in NC election
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Quanterix Corp
(NQ:
QTRX
)
12.78
+0.37 (+2.98%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
221,776
Open
12.50
Bid (Size)
12.26 (1)
Ask (Size)
13.30 (1)
Prev. Close
12.41
Today's Range
12.45 - 12.85
52wk Range
10.50 - 29.70
Shares Outstanding
38,063,618
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Quanterix Welcomes Ivana Magovčević-Liebisch, Ph.D., J.D. to Board of Directors
October 02, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces Commercialization of p-Tau 217 Test Kit
September 30, 2024
From
Quanterix Corporation
Via
Business Wire
Performance
YTD
-52.93%
-52.93%
1 Month
-17.50%
-17.50%
3 Month
-14.17%
-14.17%
6 Month
-21.60%
-21.60%
1 Year
-34.60%
-34.60%
More News
Read More
Quanterix to Participate at the Morgan Stanley 22nd Annual Global Healthcare Conference
August 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Corp. (NASDAQ: QTRX) Highlighted for Surprising Price Action
March 01, 2024
Via
Investor Brand Network
Earnings Scheduled For February 29, 2024
February 29, 2024
Via
Benzinga
Jeffrey Elliott Appointed to Quanterix’s Board of Directors
August 19, 2024
From
Quanterix Corporation
Via
Business Wire
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
Via
InvestorPlace
Quanterix Releases Financial Results for the Second Quarter of 2024
August 08, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Presenting at Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From
Quanterix Corporation
Via
Business Wire
Earnings Preview: Quanterix
February 28, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Via
Benzinga
Quanterix To Report Second Quarter 2024 Financial Results
July 31, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Presents Data Demonstrating Successful Multi-Marker Approach for Alzheimer’s Disease Detection that is More Effective than Standalone Plasma p-Tau 217
July 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix to Participate at the Scotiabank Healthcare 1x1 Day
June 17, 2024
From
Quanterix Corporation
Via
Business Wire
A Preview Of Quanterix's Earnings
February 26, 2024
Via
Benzinga
Quanterix to Present at 45th Annual Goldman Sachs Global Healthcare Conference
June 05, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix to Present at Leerink Partners Healthcare Crossroads Conference 2024
May 22, 2024
From
Quanterix Corporation
Via
Business Wire
QTRX Stock Earnings: Quanterix Beats EPS, Beats Revenue for Q1 2024
May 07, 2024
Via
InvestorPlace
Quanterix Releases Financial Results for the First Quarter of 2024
May 07, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix To Report First Quarter 2024 Financial Results
April 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Outlines Partner Path With Labs to Expedite Building Global Alzheimer’s Disease Testing Infrastructure
March 21, 2024
From
Quanterix
Via
Business Wire
Quanterix Granted Breakthrough Device Designation from U.S. FDA for Blood-Based p-Tau 217 Test for Alzheimer’s Disease
March 04, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Releases Operating Results for Fourth Quarter and Full Year 2023
February 29, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Reschedules Q4 and Full Year 2023 Earnings Conference Call; Reaffirms 2023 Guidance
February 26, 2024
From
Quanterix Corporation
Via
Business Wire
Quanterix Announces First Collaborations with Five Health Networks to Aid the Diagnosis and Clinical Management of Individuals with Alzheimer’s Disease
February 26, 2024
From
Quanterix Corporation
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.